文献速递临床试验与 GCP流行病学与生物统计

在队列内试验设计中开展研究性药品临床试验的考量

Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product.
PubMed 文献 · Trials · 2018-01-08

本文讨论队列内试验(TwiC)设计首次应用于研究性药品临床试验(CTIMP)时的考量与调整,包括采用两阶段知情同意流程以区分试验参与者与提供对照数据的队列参与者,并说明该区分对成本、招募和评估安排的影响。作者已获得伦理和监管批准,认为经设计阶段考量后该务实高效的方法可用于其他CTIMP。

要点

  • TwiC设计首次用于CTIMP需调整以确保符合GCP和国际临床试验法规。
  • 采用两阶段知情同意流程,明确区分试验参与者与提供对照数据的队列参与者。
  • 该区分确保合规,但对成本、招募和试验评估安排产生影响。

核心结论

  • 已证明CTIMP的TwiC设计可获得伦理和监管批准,设计阶段纳入相关考量后该方法可用于其他CTIMP。

研究设计与样本

  • 本文为评论文章,描述将TwiC设计用于CTIMP时所需考量与调整,未报告具体样本量。

主要发现

  • 采用两阶段知情同意流程并明确区分试验参与者与提供对照数据的队列参与者,可确保合规。
  • 该区分对成本、招募和试验评估安排产生影响。

关键数值与推荐

  • 推荐使用两阶段知情同意流程,并利用同意阶段明确区分试验参与者与提供对照数据的队列参与者。

临床怎么用

  • 在CTIMP的TwiC设计阶段纳入两阶段知情同意及参与者区分等考量,以符合GCP和国际临床试验法规。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 'trials within cohorts' (TwiC) design is a pragmatic approach to randomised trials in which trial participants are randomly selected from an existing cohort. The design has multiple potential benefits, including the option of conducting multiple trials within the same cohort. MAIN TEXT: To date, the TwiC design methodology been used in numerous clinical settings but has never been applied to a clinical trial of an investigational medicinal product (CTIMP). We have recently secured the necessary approvals to undertake the first CTIMP using the TwiC design. In this paper, we describe some of the considerations and modifications required to ensure such a trial is compliant with Good Clinical Practice and international clinical trials regulations. We advocate using a two-stage consent process and using the consent stages to explicitly differentiate between trial participants and cohort participants who are providing control data. This distinction ensured compliance but had consequences with respect to costings, recruitment and the trial assessment schedule. CONCLUSION: We have demonstrated that it is possible to secure ethical and regulatory approval for a CTIMP TwiC. By including certain considerations at the trial design stage, we believe this pragmatic and efficient methodology could be utilised in other CTIMPs in future.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Bibby AC, Torgerson DJ, Leach S, et al. Commentary: considerations for using the 'Trials within Cohorts' design in a clinical trial of an investigational medicinal product. Trials. 2018. PMID: 29310706. doi:10.1186/s13063-017-2432-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。